Insurance that actually adjudicates
A commercial plan that covers the NDC, plus a savings card the member is allowed to use, is often about $25. That is the cheapest common branded month in 2026.
A Medicare demonstration approval is $50. That is cheaper than cash. It is not cheaper than a working $25 commercial card, and it is the wrong path for Part D-covered indications.
Insurance that is a brochure
Exclusion, failed PA, government coverage that blocks the card, no Part D, already filled a 2026 Part D GLP-1, BMI tier miss — these are cash facts wearing an insurance card.
Manufacturer cash: Foundayo lowest dose often ~$149 via LillyDirect; Wegovy pill 4 mg $149 through 31 August 2026, then $199; maintenance often $299. Confirm the page on fill day.
The bundle that impersonates insurance
Telehealth offers that wrap visit plus drug near $449 are usually worse than cash plus a local clinician. They are not Part D. They are not Bridge. They do not create TrOOP.
Illegal 'insurance math'
A commercial savings card on Medicare, Medicaid, or TRICARE. A Bridge filing for T2D, moderate-to-severe OSA, or MASH to dodge Part D. Someone else's card. Those are not savings. They are rejected stacks.
What the comparison is for
VitalHound names a recommended path and prints the PA or cash checklist. It does not bill your plan and does not sell the drug.
Questions
If my copay is $25 after the card, do I still need a PA?
Does paying cash help me hit the Part D cap?
Is Bridge 'insurance' for this comparison?
When is cash the recommended VitalHound path?
Not sure this applies to you?
Answer a few questions and see your own numbers.
Free to see which path is likely cheapest for your coverage.
Check my options